A symbolic vote in the Senate last week failed to reverse President Trump’s 10% tariffs on imported goods.
Why it matters: CAP members are concerned about the impact of rising costs on pathology services.
The details: GOP Sens. Susan Collins (R-ME), Lisa Murkowski (R-AK), and Rand Paul (R-KY) voted with Democrats, but the resolution failed in a 49-49 tie vote.
The big picture: Senate GOP leadership pressured moderates, emphasizing the measure would undo tariffs on China.
- A similar resolution on Canada tariffs passed with some GOP support.
Zoom in: At the 2025 House of Delegates and Pathologists Leadership Summit, pathologists said rising costs of lab supplies are evidence that new US trade policies are starting to impact laboratory budgets.
The CAP is considering legislation to allow the President, with Congressional approval, to negotiate lower trade barriers and diversify imports for medical supplies.
- The CAP is also working with other groups to highlight the risks of tariffs on medical supplies.